Posts

Showing posts with the label Fabry Disease Drugs

Redefining Fabry Disease Treatment: A Comprehensive Overview

Image
  Fabry Disease: Epidemiology and Statistics Fabry Disease is a rare genetic disorder, affecting approximately 1 in 40,000 to 60,000 individuals worldwide. Despite its low prevalence, Fabry Disease is a significant concern in the medical community due to its debilitating effects on those affected. It primarily affects males but can also occur in females. Current Fabry Disease Treatment Market Outlook and Persisting Unmet Needs The Fabry Disease treatment market has seen significant advancements in recent years. Enzyme replacement therapy (ERT) has been the cornerstone of treatment, but it's not without limitations. ERT mainly alleviates symptoms but doesn't offer a cure. Additionally, it's expensive and requires lifelong administration. Emerging Therapies and Their Place in Evolving Fabry Disease Treatment Approach The emergence of novel therapies has brought hope for Fabry Disease patients . Substrate reduction therapy (SRT) and gene therapy are promising approaches. SRT...